Michal Tkaczyszyn

Wroclaw, DS, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Circulating metabolomic and lipidomic profiles distinguish patients with acute heart failure de novo vs. worsening of heart failure.

Circulating metabolomic and lipidomic profiles distinguish patients with acute heart failure de novo vs. worsening of heart failure.

Journal: Polish archives of internal medicine
Published: July 07, 2026

Factors associated with quality of life in patients with heart failure and its impact on mortality.

Factors associated with quality of life in patients with heart failure and its impact on mortality.

Journal: Kardiologia polska
Published: April 24, 2026

Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure.

Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure.

Journal: ESC heart failure
Published: April 17, 2026

Landmark Clinical Trials Shaping Contemporary Guideline-Directed Medical Therapy for Heart Failure.

Landmark Clinical Trials Shaping Contemporary Guideline-Directed Medical Therapy for Heart Failure.

Journal: ESC heart failure
Published: April 17, 2026

From underrecognition to structured care: ATTR cardiac amyloidosis in Poland. Insights from a multicenter national cohort.

From underrecognition to structured care: ATTR cardiac amyloidosis in Poland. Insights from a multicenter national cohort.

Journal: Kardiologia polska
Published: December 30, 2025

Cardiogenic shock in the course of myocardial infarction: the results of the Shock-POL registry.

Cardiogenic shock in the course of myocardial infarction: the results of the Shock-POL registry.

Journal: ESC heart failure
Published: December 17, 2025

Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure Journal.

Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure Journal.

Journal: European journal of heart failure
Published: December 16, 2025

Transthyretin amyloid cardiomyopathy-new data regarding epidemiology, diagnosis, and treatment.

Transthyretin amyloid cardiomyopathy-new data regarding epidemiology, diagnosis, and treatment.

Journal: ESC heart failure
Published: October 18, 2025

Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure with reduced ejection fraction undergoing scheduled hospitalization: the HEROES study.

Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure with reduced ejection fraction undergoing scheduled hospitalization: the HEROES study.

Journal: Polish archives of internal medicine
Published: October 14, 2025

Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients.

Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients.

Journal: ESC heart failure
Published: August 12, 2025

How does direct oral anticoagulant dosage affect long-term prognosis in patients with atrial fibrillation and heart failure? Results from the HEart failure ObsErvational Study (HEROES).

How does direct oral anticoagulant dosage affect long-term prognosis in patients with atrial fibrillation and heart failure? Results from the HEart failure ObsErvational Study (HEROES).

Journal: Kardiologia polska
Published: May 19, 2025

Atrial fibrillation in patients with heart failure with reduced, mildly reduced, and preserved ejection fraction: A report from the HEart failuRe ObsErvational Study (HEROES).

Atrial fibrillation in patients with heart failure with reduced, mildly reduced, and preserved ejection fraction: A report from the HEart failuRe ObsErvational Study (HEROES).

Journal: Kardiologia polska
Published: March 28, 2025
Showing 1-12 of 46

Last Updated: 09/26/2026